Edinburgh Research Explorer

Development of anti-galectin-3 antibodies for the treatment of Idiopathic Pulmonary Fibrosis (IPF)

Project: Research

StatusFinished
Effective start/end date1/09/1730/11/18
Total award£114,631.00
Funding organisationMRC
Funder project referenceMRC/CIC5/09
Period1/09/1730/11/18